DE3068844D1 - Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors - Google Patents

Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors

Info

Publication number
DE3068844D1
DE3068844D1 DE8080300692T DE3068844T DE3068844D1 DE 3068844 D1 DE3068844 D1 DE 3068844D1 DE 8080300692 T DE8080300692 T DE 8080300692T DE 3068844 T DE3068844 T DE 3068844T DE 3068844 D1 DE3068844 D1 DE 3068844D1
Authority
DE
Germany
Prior art keywords
recognin
recognins
chemoreciprocals
globulins
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080300692T
Other languages
German (de)
English (en)
Inventor
Samuel Dr Bogoch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3068844D1 publication Critical patent/DE3068844D1/de
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4731—Recognins, e.g. malignin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3015—Breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/473—Recognins, e.g. malignin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
DE8080300692T 1979-03-09 1980-03-06 Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors Expired DE3068844D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1907879A 1979-03-09 1979-03-09

Publications (1)

Publication Number Publication Date
DE3068844D1 true DE3068844D1 (en) 1984-09-13

Family

ID=21791299

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080300692T Expired DE3068844D1 (en) 1979-03-09 1980-03-06 Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors

Country Status (4)

Country Link
EP (1) EP0015755B1 (https=)
JP (1) JPS55167265A (https=)
AT (1) ATE8897T1 (https=)
DE (1) DE3068844D1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
EP0221748A3 (en) * 1985-11-01 1988-10-12 Samuel Dr. Bogoch A process for the production of human antibodies
EP0681480B1 (en) * 1993-03-16 2004-01-07 Samuel Dr. Bogoch Recognin vaccines
JP4901339B2 (ja) * 2006-07-05 2012-03-21 積水メディカル株式会社 細胞に取り込まれた被験化合物の定量方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4830445A (https=) * 1971-08-24 1973-04-21
US4160019A (en) * 1973-06-25 1979-07-03 Bjorklund Knut B Detection of cancer associated polypeptide antigen and preparation of antibodies thereto
JPS50103037A (https=) * 1974-01-25 1975-08-14
GB1533464A (en) * 1975-02-18 1978-11-22 Bogoch S Cancer diagnostic agents
GB1524221A (en) * 1975-08-01 1978-09-06 Bogoch S Cancer diagnostic agents
GB1532803A (en) * 1975-10-15 1978-11-22 Bogoch S Cancer diagnostic agents
DE2546670A1 (de) * 1975-10-17 1977-04-21 Samuel Bogoch Recognine
JPS52104649A (en) * 1976-02-28 1977-09-02 Toyoda Gosei Kk Gear with plastic shaft
DE2824917A1 (de) * 1977-07-13 1979-02-01 Corning Glass Works Biologisch aktive konjugate
DE2967534D1 (en) * 1978-07-07 1985-11-28 Bogoch Samuel Product for detecting the presence of cancerous or malignant tumor cells

Also Published As

Publication number Publication date
JPS55167265A (en) 1980-12-26
JPS6362517B2 (https=) 1988-12-02
EP0015755B1 (en) 1984-08-08
EP0015755A2 (en) 1980-09-17
EP0015755A3 (en) 1980-12-10
ATE8897T1 (de) 1984-08-15

Similar Documents

Publication Publication Date Title
Blakeslee et al. Immunofluorescence using dichlorotriazinylaminofluorescein (DTAF) I. Preparation and fractionation of labelled IgG
Toohey A vitamin B12 compound containing no cobalt.
Davis et al. A simple modified carbodiimide method for conjugation of small-molecular-weight compounds to immunoglobulin G with minimal protein crosslinking
EP0221748A3 (en) A process for the production of human antibodies
AU6356986A (en) Ma6 anti human breast cancer for imaging process
RO82758B (ro) Procedeu de preparare a unor imunoglobuline conjugate
DE3068844D1 (en) Recognins, their chemoreciprocals, target attaching globulins and processes for producing these products; methods of detecting cancer tumors
JPS6463393A (en) Monoclonal antibody
FI891718A0 (fi) Foerfarande foer att befria cellblandningar och vaevnader av icke-oenskade populationer.
DE3163746D1 (en) Beta-d-arabinofuranosylimidazo (4,5-c)pyridine compounds and processes for their production
DE3151738C2 (https=)
IE42521L (en) Treating a sodium lauryl sulphate-whey protein complex.
Estrada-Parra et al. Reaction of adenine-specific antibodies with denatured deoxyribonucleic acid
WO1997024618A1 (de) Verfahren zur markierung von biomolekülen mit meerrettichperoxidase
JPH11510785A (ja) ヒスチジン部分を有する融合ポリペプチドに作用する抗体
GB1524221A (en) Cancer diagnostic agents
JPS5483989A (en) Preparation of hydrophilic polymer
IE781891L (en) Fibrous milk protein product.
DE3426077A1 (de) Monoklonale antikoerper gegen humanes ifn-(gamma), diese antikoerper produzierende hybridzellinien, verwendung der neuen antikoerper und verfahren zu deren herstellung
Knüfermann et al. Peptide cleavage in sheep erythrocyte membranes during the action of complement
JPS5522691A (en) Manufacture of r*ss55pphydroxyphenyll2*44 imidazolidione or r*ss55pphydroxyphenylhydantoin
WO1986002651A3 (en) Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
PT684835E (pt) Antagonistas de ligandos para o tratamento do cancro da mama
GB1532803A (en) Cancer diagnostic agents
IE782469L (en) Light absorbing substance

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee